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 INTRODUCTION 
 Hendra virus (HeV) and Nipah virus (NiV) are zoonotic 
viruses responsible for outbreaks of respiratory and neu-
rological disease in livestock and humans. Both belong to 
the genus  Henipavirus , subfamily  Paramyxovirinae family 
 Paramyxoviridae , and order  Mononegavirales . 
 Originally isolated from humans and domestic animals, 
pteropid bats have been identified as the reservoir for both 
viruses. HeV antibody was first identified in the serum of 
 Pteropus sp. bats in 1996 followed by the isolation from a 
grey-headed flying fox,  Pteropus poliocephalus and a black 
flying-fox Pteropus alecto. 1, 2 Subsequently, both  Pteropus 
spp. occurring in Malaysia were found seropositive for NiV 
neutralizing antibodies, and the virus has been isolated from 
 Pteropus hypomelanus and  Pteropus vampyrus . 3– 5 
 HeV was initially isolated from the uterine fluid of a 
 P. poliocephalus female that had miscarried and from fetal 
tissues. 2 NiV has been isolated from pools of voided urine of 
 P. hypomelanus collected by Chua and others 4 from under 
roosting bat colonies, from urine  of Pteropus lylei in Cambodia, 
using similar techniques, and from the urine of a wild-caught 
 P. vampyrus in peninsular Malaysia. 5, 6 
 In this study, we attempted to identify the routes of transmis-
sion between bats and their spillover hosts by using geographi-
cally appropriate henipaviruses and hosts. Specifically, we aim 
to determine routes of virus excretion in bats and whether 
their gender or pregnancy status influenced the amount and 
route of excreted virus. This work outlines the experimental 
studies and the detailed findings. 
 MATERIALS AND METHODS 
 Animals.  Twenty wild-caught adult  Pteropus alecto bats 
from Queensland, Australia (12 pregnant females [Bats 1–12], 
five non-pregnant females [Bats 13–17], and three males 
[Bats 18–20]) and eight wild-caught adult  P. vampyrus bats 
from Malaysia (four non-pregnant females [Bats 21–24] and 
four males [Bats 25–28]) were used in these experiments. 
 Pteropus alecto was chosen because its distribution overlaps 
the locations where HeV outbreaks have occurred and it is 
the most abundant species of flying fox in Australia.  Pteropus 
vampyrus was chosen because its distribution overlaps the 
putative location of the NiV spillover in Malaysia, which led 
to the 1998–9 outbreak. 
 Australian bats were kept in captivity in Queensland 
(3 weeks) before shipment to the Commonwealth Scientific 
and Industrial Research Organization (CSIRO) Australian 
Animal Health Laboratory (AAHL). The Malaysian bats were 
kept at Taiping Zoo (3 months) before export to Australia. 
All animals were seronegative to henipavirus infection on 
the basis of virus neutralization tests (VNTs) at the time of 
 capture and for the period before the experiment. Animal 
husbandry methods and experimental design were endorsed 
by the CSIRO AAHL’s Animal Ethics Committee (protocol 
no. 1023). For the duration of the study, bats were housed in a 
single room at Biosafety level 4 (BSL-4). Room temperature 
was maintained at 22°C with 15 air changes/hour. Humidity 
varied between 40% and 60%. Bats were housed individually 
in squeeze bottom cages (750 mm wide by 570 mm deep and 
600 mm high). They were fed a variety of fresh fruit and pro-
vided with water ad lib. Bat weights were recorded before the 
start and periodically throughout the study. 
 Before experimentation, animals were immobilized with a 
mixture of ketamine HCl (5 mg/kg) (Ketamil; Ilium, Glen-
denning, Australia) and medetomidine (50 μg/kg) (Domitor; 
Novartis, Pendle Hill, Australia) by intramuscular injection . 
For reversal, atipamezole (Antisedan; Novartis) was given 
intramuscularly at 50% of the dose used for medetomidine. 
At termination of the study, bats were immobilized as above, 
with euthanasia by cardiac exsanguination. Serology, virus 
isolation, and the initial stages of RNA extraction were also 
carried out at BSL-4; staff wore fully encapsulated suits with 
breathing apparatus. 
 Viral inoculum.  HeV used to infect Australian bats was 
originally isolated from  P. poliocephalus . 2  P. alecto bats were 
infected with Vero cells (passage #6) cell culture supernatant 
(1.5 × 10 7 TCID 50 /mL). Because of the unavailability of a bat 
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isolate for NiV, the virus used to infect the Malaysian bats was 
originally isolated from the central nervous system of persons 
with fatal NiV encephalitis during the 1999 outbreak in 
Malaysia. A stock of low passage virus was grown in Vero cells 
and used to infect  P. vampyrus individuals. The cell culture 
supernatant had a titer of 5 × 10 5 TCID 50 /mL. 
 Experimental infections.  The study was conducted in three 
parts: Part 1, 12 pregnant  P. alecto ; Part 2, 8  P. alecto ; and 
Part 3, 8  P. vampyrus . The  P. alecto were exposed oronasally 
as described previously with 50 × 10 3 TCID 50 HeV. The 
 P. vampyrus were exposed by dripping 1 mL of inoculum 
(50 × 10 3 TCID 50 NiV) into the nostrils and throat and then 
rechallenged on Day 28 with the same virus inoculum by the 
same route. Clinical signs were assessed daily. In Part 1 and 2, 
animals were sampled, and rectal temperatures recorded every 
second day for 19 days. In Part 3, animals were sampled every 
second day for 21 days, and every second day from Days 30 to 
42. Blood, urine, throat, and rectal swabs were collected at each 
sampling. Urine was collected by gentle manual compression 
of the bladder. Blood was collected from either the marginal 
wing vein or the uropatagial vein using a 25 gauge needle 
and 3 ml syringe. Swabs were placed immediately into 1 mL 
of viral transport medium (phosphate buffered saline [PBS] 
containing 100 U Penicillin, 100 μg/mL Streptomycin, and 
500 μg/mL Fungizone). All specimens were stored at −80°C. 
Blood for serology was collected from Australian bats on 
either Day 10 or 11 and at postmortem, and from Malaysian 
bats on Days 14, 21, 28, 35, 42, and at postmortem. 
 The Australian bats were euthanaized on Day 20, 21, or 22 
and a wide range of tissues were collected for analysis. The 
Malaysian bats were rechallenged on Day 28, and the experi-
ment terminated on Day 49, 50, or 51 when a wide range of tis-
sues were collected at postmortem. 
 Samples were analyzed for the presence of  henipavirus 
genome by TaqMan analysis. Virus isolation was only at -
tempted on samples that were positive by TaqMan analysis. 
Seroconversion was assessed by virus neutralization. Tissues 
were also preserved in formalin and prepared for immunohis-
tochemical staining and histopathological analysis. 
 Serology.  A VNT was used, with either 100 TCID 50 NiV or 
100 TCID 50 HeV and Vero cells as previously described. 
7 Serum 
neutralizing titers were recorded as the reciprocal of the serum 
dilution. Positive and negative controls and a back-titration of 
the virus were included in each test. Serum samples with a titer 
of 1/10 and above were assessed to be positive. Serology was 
carried out at BSL-4. At the time of these experiments other 
assays including Bioplex assays were not available. 
 HeV and NiV genome Taqman polymerase chain reaction 
assays.  Samples collected during the study and tissues col-
lected aseptically at postmortem were assayed for the detec-
tion of henipavirus genome by TaqMan assay as previously 
described. 7, 8 
 Primers and TaqMan probe to detect HeV genome and NiV 
genome were designed from the N gene sequence of HeV 
(Genbank accession no. AF017149) and NiV (Genbank acces-
sion no. AF212302), respectively, using specified criteria in the 
Primer Express Software version 1.5 (Applied Biosystems, 
Foster City, CA). The specific HeV oligonucleotide primers 
were: Hendra-N1433F 5′-atc tca gat cca gat tag ctg caa-3′ and 
Hendra-N1572R 5′-atc att ttg ggc agg ttt gg-3′. The fluorogenic 5′ 
nuclease (TaqMan) probe was Hendra 1642comp 5′-[6-carboxy-
fluorescein (FAM)]-cct ggt cat ctt tcc ttc ct-3′-[MGBNFQ]. 
The specific NiV oligonucleotide primers were: Nipah-
N1198F 5′-tcagcaggaaggcaagagagtaa-3′ and Nipah-N1297R 
5′-ccccttcatcgatatcttgatca-3′. The fluorogenic 5′ nuclease 
(Taq Man) probe was Nipah 1247comp 5′-[6-carboxy-fluorescein 
(FAM)]-tgctggcaccagacttgccctc-3′-[6-carboxy-tetramethyl 
rhodamine (TAMRA)]. 
 Assays were performed using a two-step protocol consisting 
of an initial reverse transcription (RT) reaction followed by 
complementary DNA (cDNA) amplification . The appropri-
ate virus inoculum was used as the positive control in the 
TaqMan assays. All TaqMan reagents were purchased from 
Applied Biosystems except primers, which were manufac-
tured by Geneworks (Hindmarsh, Australia). RNA was 
reverse transcribed using the TaqMan Gold RT-polymerase 
chain reaction (PCR) kit (Applied Biosystems). RNA 
(3.5 μL) diluted to 500 μg/3.5 μL (tissue samples) or undi-
luted (swabs, urine, and blood) was added to 6.5 μL of a reac-
tion mix containing 1× TaqMan RT buffer, 5.5 mM magnesium 
chloride, 2 mM deoxyNTP mixture, 2.5 μM random hexamers, 
0.4 U/μL RNase inhibitor, and 1.25 U/μL MultiScribe reverse 
transcriptase. The samples were reversed transcribed in a Px2 
thermal cycler (Hybaid; Thermo Scientific, Wilmington, MA) 
at 22°C for 15 min, 48°C for 30 min, and 95°C for 5 min. The 
cDNA (5 μL) was added to 20 μL of PCR reaction mix in 
each well of a MicroAmp (Applied Biosystems) optical reac-
tion plate containing 12.5 μL of Taqman Universal PCR mas-
termix, 3.75 μL distilled water, 1.25 μL each of 18 μM forward 
and reverse primers, and 1.25 μL of 5 μM labeled probe. 
 The samples were tested in duplicate and amplified in 
a GeneAmp 7700 Sequence Detection System (Applied 
Biosystems) using the following program: 50°C for 2 min, 
1 cycle; 95°C for 10 min, 1 cycle; 50 cycles at 95°C for 15 s, 60°C 
for 60 s. Primer and probe optimization experiments were 
done as recommended in the AB7700 Sequence Detection 
System protocol. A dilution series was made of each primer 
and probe set to determine the optimum concentrations (data 
not shown). Samples were positive if the cycle threshold (C T ) 
value was < 45 cycles. If a sample tested positive it was then 
retested in triplicate along with a random selection of nega-
tive samples that were also tested in triplicate. The average 
retested C T value was recorded. Where only one or two wells 
in the triplicate testing registered a C T value < 45, an indeter-
minate result was recorded. 
 Virus isolation.  Samples that tested positive or indeterminate 
for henipavirus genome by TaqMan assay were then processed 
for virus isolation in Vero cells. A 10% w/v homogenate of 
tissue samples was prepared, blood was diluted 1 in 10 with 
PBS, and the fluids from swabs and urine were tested neat, as 
previously described. 9 
 Histopathologic and immunohistochemical methods.  Sub-
mandibular lymph node, submandibular salivary gland, ad renal 
gland, tonsil, lung, kidney, bladder, spleen, heart, forebrain, 
hindbrain, liver, pancreas, mesenteric lymph node, ileum, 
genital and gonadal tissues (placenta, ovary, uterus, vagina, 
testis, penis), and bone marrow (hyoid and laryngeal bones) 
were collected. From Part 1, fetal tissues were collected from 
the pregnant bats, and these typically included intestine, 
kidney, lung, liver, brain, pancreas, adrenal, heart, and spleen. 
Tissues were fixed in 10% neutral buffered formalin, processed 
through to paraffin. A rabbit polyclonal anti-Nipah virus 
antibody was used as the primary antibody for tissues collected 
from the Malaysian bats and a rabbit polyclonal anti-Hendra 
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virus antibody was used as the primary antibody for tissues 
collected from the Australian bats. Immunohistochemistry 
protocols were as described previously. 10 
 RESULTS 
 Animals.  The 12 pregnant  P. alecto bats were captured in 
south-east Queensland in July 2003. The remaining  P. alecto 
bats were captured from the same site in January 2004, with 
this timing overlapping the end of the birthing season for this 
species. The  P. vampyrus bats were captured in Peninsular 
Malaysia in late 2005. The weights for all bats ( P. alecto and 
 P. vampryus ), ranged from 540 g to 1,000 g. 
 Clinical observations.  All bats remained clinically well 
throughout the study period. No febrile responses were 
recorded in either Part 1 or 2 of the experiment after virus 
inoculation. Because of the absence of a febrile response, 
rectal temperatures were not recorded in Part 3. All animals 
maintained their initial bodyweight or exhibited a slight gain 
in weight and ate copious amounts of fruit. 
 Detection of henipavirus genome.  All samples collected 
were screened by TaqMan RT-PCR for either HeV or NiV 
genome, depending on the inoculum. Positive HeV TaqMan 
results for urine, blood, throat, and rectal swab samples are 
shown in  Table 1 . The table indicates the average cycle number 
(C T value) at which the sample was positive for the detection 
of HeV genome when tested in triplicate. Indeterminate 
samples, where only one or two wells registered a C T value 
of < 45 were also recorded. There were 46 samples that were 
positive for the detection of HeV genome, and an additional 
18 indeterminate results. 
 At postmortem, a limited range of tissues were positive for 
the detection of HeV genome and these all came from bats 
that had samples test positive for HeV genome during the 
clinical sampling period ( Table 2 ). The data does not indicate 
an association between virus replication and virus shedding 
with pregnancy. It should be noted that as animal numbers 
were unavoidably limited (because of the restrictions work-
ing within a BSL-4 environment) no statistical analyses could 
be undertaken. 
 Only two samples tested positive for NiV genome, both 
from Bat 22; one from a throat swab on Day 4, and one from a 
rectal swab on Day 8 (data not shown). No postmortem tissues 
tested positive for NiV genome (data not shown). 
 Virus isolation.  Samples positive or indeterminate for heni-
pavirus genome were inoculated onto cells for virus isolation. 
For Parts 1 and 2, this amounted to 64 premortem samples 
and 10 postmortem samples ( Table 2 ), and in Part 3, only two 
samples (throat swab and rectal swab from Bat 22). Virus was 
isolated from one non-pregnant female bat (Bat 16), on three 
occasions, twice from urine on consecutive sampling days (Days 
6 and 8) and once from a rectal swab on Day 6. The amount of 
virus recovered was at the limit of detection (virus titer < 1/8). 
 Postmortem.  No gross abnormalities were identified on 
gross postmortem examination of the bats. At postmortem Bat 
15 was noted to be in the early stages of pregnancy. 
 Histopathology and immunohistochemistry.  Histopatholog-
ical abnormalities were few. In the adrenal gland of Bat 8 
there was severe, diffuse, subacute necrosis and hemorrhage 
of the zona fasciculata and zona reticularis extending into the 
adrenal medulla consistent with the exhaustion phase of a 
stress response. The fetal liver from Bat 6 had mild periportal 
mononuclear cell infiltration suggesting antigenic exposure. 
The endometrial glands of Bats 13 and 16 were distended, 
indicating possible oestrus, or perioestral activity, and Bat 15 
was in the early stages of pregnancy. The testicular tissue was 
in active spermatogenesis in Bat 18 only. All tissues examined 
were negative on immunohistochemical staining for HeV or 
NiV antigen including the kidney and bladder of Bat 16. 
 Serology.  Table 3 shows a summary of the serology results 
from Parts 1 and 2 indicating the virus neutralizing titer and 
 Table 1 
 C T values for the HeV TaqMan positive samples from  Pteropus alecto . 
 *  C T values represent the cycle number at which a sample became positive for the detection 
of HeV genome. (*) represents an indeterminate result (i.e., only one or two wells in a trip-
licate tested positive). The pattern of genome detection is shown with the circles. The black 
circle highlights the detection of genome on mucosal surfaces. The broken circle highlights the 
detection of genome in blood and urine, representing a systemic infection. Virus was isolated 
in cell culture from urine collected from Bat 16 on Days 6 and 8. 
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day of collection. In Part 1, by postmortem, 50% (6/12) bats 
had virus neutralizing titers ranging from 1/10 to 1/40. There 
was an additional bat that showed fleeting virus neutralization 
in serum at Day 10 with a titer of 1/10. In Part 2, three bats 
showed virus neutralization by the time of postmortem, with 
the maximum titer being 1/40.  Table 4 shows a summary of 
the serology from Part 3, where for the first 3 weeks of the 
experiment, virus neutralization patterns mirrored those seen 
in the Australian bats and by Day 21 two bats had titers of 1/10. 
However, 7 days later, this had risen to 5/10 animals. It was at 
this point that bats in Part 3 were rechallenged. Seven days 
after this rechallenge another bat showed virus neutralization 
by serum, and by the conclusion of the experiment (Day 49+), 
the serum of 7/8 bats neutralized NiV. 
 DISCUSSION 
 This study confirms that while healthy  Pteropus bats can 
be experimentally infected with henipaviruses productive 
infections (generation of high titer progeny viruses) were not 
established. One non-pregnant female  P. alecto shed HeV in 
urine on Day 6 and Day 8 postexposure and had HeV genome 
in kidney at postmortem examination. Isolation of henipavirus 
from bat urine is consistent both with previously published lab-
oratory data and field surveillance. In one study using a native 
Australian bat ( P. poliocephalus ), NiV was isolated on three 
occasions from the urine of a single bat. 10 Similarly, Chua and 
others 4 recovered the first pteropid NiV isolate from urine col-
lected beneath the roost of  P. hypomelanus and, subsequently, 
NiV was similarly isolated from the urine of  P. lylei and from a 
wild-caught  P. vampyrus . 5, 6 The presence of live virus in a rec-
tal swab of the same bat on Day 6 is quite likely to be a con-
taminant from urine as the sampling procedure started with 
urine collection. Urine expression by manual bladder palpa-
tion in females did result in some contamination of fur in the 
urogenital region. Additionally, there was no other rectal swab 
isolate of HeV from this or any other bat. 
 In this study NiV was not recovered from exposed Malaysian 
bats. Nipah virus genome detection in samples was also very 
low (2/512). Both positive samples were from the same female 
bat; one being a throat swab on Day 4 and the other a rectal 
swab on Day 8. Although it is possible these results reflected 
primary inoculum on mucosal surfaces, it is our experience 
(in other species) that clearance of henipavirus inoculum 
occurs within 48 hours of its administration (unpublished 
data). Detection of genome without the subsequent detection 
 Table 4 
 NiV serum neutralizing titers of the  Pteropus vampyrus bats * 
Bat no.
Nipah virus serum neutralizing titer
Day 14 Day 21 Day 28 Day 35 Day 42 Postmortem ‡ 
21 ≤ 1/5 ≤ 1/5 1/10 1/10 1/80 1/80
22 ≤ 1/5 1/10 1/10 1/20 1/40 1/20
24 ≤ 1/5 ≤ 1/5 ≤ 1/5 ≤ 1/5 1/40 1/20
25 ≤ 1/5 ≤ 1/5 1/10 1/20 1/20 1/40
26 ≤ 1/5 ≤ 1/5 ≤ 1/5 1/20 ≤ 1/5 1/10
27 1/80 1/10 1/40 1/40 1/20 1/40
28 ≤ 1/5 ≤ 1/5 ≤ 1/5 ≤ 1/5 ≤ 1/5 1/10
 *  Bats were rechallenged with NiV after serum sampling on Day 28. Bat 23 remained sero-
negative (≤ 1/5) throughout the experiment. 
 ‡  Postmortems were conducted on either Day 49, 50, or 51 days postinoculation. 
 Table 2 
 Bats that tested positive for the detection of HeV genome during the sampling period and at  postmortem , together with their antibody status at 
postmortem 
Sex (M/F), pregnant (P) Bat number TaqMan + ve samples
Sampling day number (postinoculation) 
of the positive sample TaqMan + ve PM tissues Antibody status at post mortem
F (P) 3 Throat swab 6 Lung −ve
F (P) 5 Throat swab 4, 6 None −ve
F (P) 7 Throat swab 2 None −ve
F (P) 9 Throat swab 3, 7 Spleen 1/10
Rectal swab 3, 5, 9
Blood 13
F (P) 10 Throat swab 3 None −ve
Rectal swab 3, 5, 7
Urine 3
F 13 Rectal swab 4 Spleen 1/20
Urine 10, 12
Blood 10, 12
F 16 Rectal swab 7, 15 Spleen 
Liver 
Kidney
−ve
Urine 7, 9, 11, 13, 15, 17, 19
Blood 7, 9, 11, 13, 15
F 17 Rectal swab 7 Spleen 
Lung 
Liver
1/40
Urine 11, 13, 15
Blood 5, 7, 9, 11, 13, 15
M 19 Rectal swab 7 None −ve
M 20 Blood 16, 18 Spleen −ve
 Table 3 
 The HeV serum neutralizing titers of the  Pteropus alecto bats at 10 
days postinoculation and at  postmortem ; all other bats (3, 5, 6, 7, 
10, 14, 15, 16, 19, 20) remained seronegative (≤ 1/5) throughout the 
experiment 
Bat no.
Hendra virus serum neutralizing titer
Day 10 pi Postmortem † 
1 1/20 1/10
2 1/20 1/10
4 1/40 1/20
8 1/20 1/40
9 1/20 1/10
11 1/80 1/40
12 1/10 ≤ 1/5
13 ≤ 1/5 1/20
17 ≤ 1/5 1/40
18 1/20 1/20
 †  Postmortems were conducted on either Day 20, 21, or 22 postinoculation . 
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of live virus has been seen in other studies. In a recent study 
involving  P. alecto Japanese encephalitis virus was transmitted 
from experimentally infected bats to mosquitoes despite the 
absence of a detectable viraemia. 11 In only one experimentally 
infected bat was Japanese encephalitis virus genome detected 
by TaqMan RT-PCR and this was at a very high cycle number, 
indicating very low levels of genome. The sample did not yield 
viable virus when inoculated onto cells, confirming the very 
low levels of virus. 
 The greatest incidence of HeV genome detection in rectal 
and throat swabs was in the first 7 days post challenge, whereas 
the majority of urine and blood samples with detectable HeV 
genome were collected after Day 7 ( Table 1 ). This is consistent 
with intranasal exposure of HeV being followed by replication 
in mucosal surfaces with subsequent systemic infection. In this 
and other experiments virus isolation from exposed  Pteropus 
bats coincided with the timing of the proposed systemic infec-
tion, at least 6 days after exposure to the virus. 10, 12 
 Only 1 in 20 bats shed infectious HeV. The virus was at low 
titers and was detected over a narrow time frame. Previous stud-
ies have not reported the titer of henipavirus recovered from 
bats; however, the low frequency of virus isolation is consistent 
with field data. We conclude that the opportunity for spillover 
of HeV from healthy bats is limited both by the amount of 
excreted virus and the time over which it is excreted. It fol-
lows that for an outbreak of Hendra virus to occur, a suscep-
tible spillover species would need to be exposed, most likely 
to urine from an infected bat, within a very narrow window of 
opportunity. It is possible that this window is enlarged by cer-
tain physiological or immunological factors in some individual 
bats. Our data do not support either pregnancy or stress in the 
conventional sense being such a factor, however it should be 
noted that because of low experimental numbers the finding 
may not reflect the situation in nature. Similarly, when naive 
colonies are exposed to HeV and many individuals become 
simultaneously infected, there may be an increased likelihood 
of a susceptible host receiving an infectious dose. The latter 
mechanism has been proposed as an explanation for the spo-
radic nature of HeV outbreaks in horses. 13 
 Inoculated bats survived Nipah virus challenge without 
developing clinical disease consistent with previous studies. 10 
We conclude that the opportunity for spillover of NiV from 
healthy bats is also rare, and similarly constrained by the short 
infectious period and the low intensity of infection. 
 Regarding the finding from VNTs on post-challenge serum 
samples, all positive samples had relatively low titers consis-
tent with previous studies. 12 One animal in a previous study 
did mount a significant antibody response with a titer > 1/640. 10 
However in this study, an Australian bat species ( P. polioceph-
alus ) was infected with heterologous virus (i.e., virus that natu-
rally infects a closely related species of bats; NiV) and this may 
explain the increased titer seen. 
 The consistently low virus neutralizing titers in experimen-
tal and natural henipavirus infections in bats is in contrast to 
the high titers often observed during infection of other spe-
cies. 14 In this study, the VNT profile of the NiV-infected bats 
was similar to that of the HeV-infected bats up to Day 21 pi, 
with low titers and only a small proportion of bats (2/8) test-
ing positive in the serum neutralizing test. However, by Day 
28, 50% of the  P. vampyrus had virus neutralization at low 
serum dilutions. After rechallenge on Day 28, three more 
bats showed virus neutralization by the termination of the 
experiment but in neither time frame were the patterns par-
ticularly suggestive of either a primary or anamnestic antibody 
response. 
 Leonard, Allen, and Sulkin 15 suggested that the immune 
response of bats to (arbovirus) infection enhanced their 
 effectiveness as reservoir hosts. Chakravarty and Sarkar 16, 17 
found a high percentage (~82%) of peripheral circulating 
B cells in  P. giganteus and suggested that this was evidence, 
which corroborated earlier suggestions that the immune sta-
tus of bats could be described as relatively immunodeficient. 
From our observations we do not believe that the immune 
status of bats is necessarily compromised, but rather the key 
immune responses to co-evolved pathogens may require 
alternate methods of evaluation to those described above. 
 Plowright and others 18 showed that seroprevalence rates in 
 Pteropus scapulatus suggested that pregnancy and lactation are 
risk factors for viral infection. In our study pregnancy did not 
influence recovery of live virus from infected bats. Plowright 
and others 18 also reported elevated seroprevalence in a nutri-
tionally stressed population, and suggested that there may be an 
increased susceptibility to viral infection caused by substantial 
energetic costs of immune responses. Although the bats used 
in this study were in good health, and did not lose bodyweight 
over the course of the experiment, it would be difficult to ascer-
tain whether they were stressed in a physiological sense. 
 Absence of disease in infected animals is consistent with 
previous studies. Long-term coexistence of viruses and their 
hosts has given co-evolution a good chance to reach a relative 
equilibrium, and consequently many viruses do not cause dis-
ease in their reservoir host. 19 The theory of viral co-evolution 
with chiropteran hosts has been previously suggested, and the 
findings of this study support this. 20 
 Our studies provide valuable insight into aspects of the 
dynamics of henipavirus infection in the natural flying fox 
reservoir, but many questions remain unanswered. Current 
assumptions about serology and conventional host/pathogen 
relationships, and how such data is fed into models, must be 
challenged. The most significant finding of this work is that 
infected animals exhibited little clinical or serological evidence 
of henipavirus infection or associated disease. The data from 
this study and others 18 show that pteropid bats are susceptible 
to henipavirus infection but, in general, the infections (experi-
mental and field) are non-pathogenic. Collectively, these char-
acteristics indicate that pteropid bats are true reservoir host 
species 21– 27 for henipaviruses. The data may be indicative that 
for an effective spillover event to occur, ecologically, physio-
logically or immunologically ‘primed’ bats may be necessary. 
To test this hypothesis further experimental trials are required 
to assess the impact of henipavirus infection on such animals. 
Finally, it must be noted that the inferences gained from the 
data described in this study are drawn from low numbers of 
experimental animals. 
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